Item no. |
STJ116296-50 |
Manufacturer |
St John's Laboratory
|
Amount |
50ul |
Category |
|
Type |
Antibody Polyclonal |
Applications |
WB, IP |
Specific against |
Human, Mouse |
Host |
Rabbit |
Isotype |
IgG |
ECLASS 10.1 |
32160702 |
ECLASS 11.0 |
32160702 |
UNSPSC |
12352203 |
Alias |
Anti-Insulin-Like Growth Factor 2 Mrna-Binding Protein 3 antibody</br>Anti-Igf2 Mrna-Binding Protein 3 antibody</br>Anti-Imp-3 antibody</br>Anti-Igf-Ii Mrna-Binding Protein 3 antibody</br>Anti-Kh Domain-Containing Protein Overexpressed In Cancer antibody< |
Similar products |
Anti-Insulin-Like Growth Factor 2 Mrna-Binding Protein 3 antibodyAnti-Igf2 Mrna-Binding Protein 3 antibodyAnti-Imp-3 antibodyAnti-Igf-Ii Mrna-Binding Protein 3 antibodyAnti-Kh Domain-Containing Protein Overexpressed In Cancer antibody< |
Available |
|
Clonality |
Polyclonal |
Conjugation |
Unconjugated |
Formulation |
PBS with 0.02% sodium azide, 50% glycerol, pH7.3. |
Purification |
Affinity purification |
Uniprot ID |
O00425 |
Storage |
Store at-20° C and avoid freeze-thaw cycles. |
Description |
The protein encoded by this gene is primarily found in the nucleolus, where it can bind to the 5' UTR of the insulin-like growth factor II leader 3 mRNA and may repress translation of insulin-like growth factor II during late development. The encoded protein contains several KH domains, which are important in RNA binding and are known to be involved in RNA synthesis and metabolism. A pseudogene exists on chromosome 7, and there are putative pseudogenes on other chromosomes. |
Gene ID |
|
Gene symbol |
|
Immunogen |
Recombinant fusion protein containing a sequence corresponding to amino acids 300-579 of human IGF2BP3 (NP_006538. 2). |
Short Description |
Rabbit polyclonal against IGF2BP3 |
Tissue specificity |
Expressed in fetal liver, fetal lung, fetal kidney, fetal thymus, fetal placenta, fetal follicles of ovary and gonocytes of testis, growing oocytes, spermatogonia and semen (at protein level). Expressed in cervix adenocarcinoma, in testicular, pancreatic and renal-cell carcinomas (at protein level). Expressed ubiquitously during fetal development at 8 and 14 weeks of gestation. Expressed in ovary, testis, brain, placenta, pancreatic cancer tissues and pancreatic cancer cell lines. |
Cellular localization |
NucleusCytoplasmFound In Lamellipodia Of The Leading EdgeIn The Perinuclear RegionAnd Beneath The Plasma MembraneThe Subcytoplasmic Localization Is Cell Specific And Regulated By Cell Contact And GrowthLocalized At The Connecting Piece And The Tail Of The SpermatozoaColocalized With Cd44 Mrna In Rnp GranulesIn Response To Cellular StressSuch As Oxidative StressRecruited To Stress Granules |
Molecular weight |
Calculated: 21kDa/63kDa. Observed: 70kDa |
Dilution range |
WB 1:500-1:1000 IP 1:20-1:50 |
Alternative names |
Anti-Insulin-Like Growth Factor 2 Mrna-Binding Protein 3 antibodyAnti-Igf2 Mrna-Binding Protein 3 antibodyAnti-Imp-3 antibodyAnti-Igf-Ii Mrna-Binding Protein 3 antibodyAnti-Kh Domain-Containing Protein Overexpressed In Cancer antibodyAnti-Hkoc antibodyAnti-Vickz Family Member 3 antibodyAnti-IGF2BP3 IMP3 KOC1 VICKZ3 antibody |
Protein name |
Insulin-Like Growth Factor 2 Mrna-Binding Protein 3Igf2 Mrna-Binding Protein 3Imp-3Igf-Ii Mrna-Binding Protein 3Kh Domain-Containing Protein Overexpressed In CancerHkocVickz Family Member 3 |
Note |
FOR RESEARCH USE ONLY (RUO). |
Swiss port key |
|
Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.
All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.